Anderson Raymond

DirectorMonopar Therapeutics (MNPR) · full profile →Form 4/A · filed Aug 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$352K
Net Open-Market Flow
-$352K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2026Option exercise(M)1K$30.00$42K7K
Aug 25, 2026Option exercise(M)2K$30.00$52K9K
Aug 25, 2026Sell(S)694$110.04$76K8K
Aug 25, 2026Sell(S)646$111.07$72K7K
Aug 25, 2026Sell(S)2K$113.05$204K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2026Option exercise(M)1K$03K
Aug 25, 2026Option exercise(M)2K$03K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001437749-26-029228) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about MNPR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-26-029228"
Ask your agent
Use Arkolith to summarize insider buying and selling at Monopar Therapeutics
over the last 90 days and cite the filings.